Effects of bimatoprost 0.03% on ocular hemodynamics in normal tension glaucoma

Journal of Ocular Pharmacology and Therapeutics

Volumn 22, Issue 3, 2006, Pages 188-193

  Chen, Mei Ju ^a,b   Cheng, Ching Yu ^a,b   Chen, Yen Cheng ^b   Chou, Ching Kuang ^a,b   Hsu, Wen Ming ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BIMATOPROST; LATANOPROST; TIMOLOL;

ADULT; ARTICLE; BLOOD SAMPLING; CILIARY ARTERY; CLINICAL ARTICLE; COLOR ULTRASOUND FLOWMETRY; DRUG EFFECT; EYE BLOOD FLOW; FEMALE; GLAUCOMA; HEMODYNAMIC MONITORING; HIGH RISK PATIENT; HUMAN; INTRAOCULAR PRESSURE; MALE; NORMAL TENSION GLAUCOMA; OCULAR PRURITUS; PRESSURE MEASUREMENT; PRURITUS; SENSATION; STINGING SENSATION; VASCULAR RESISTANCE;

AGED; AGED, 80 AND OVER; AMIDES; CIRCADIAN RHYTHM; FEMALE; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; LIPIDS; MALE; MIDDLE AGED;

EID: 33745875027     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2006.22.188     Document Type: Article

References (37)

1. Kaiser, H.J., and Flammer, J. Systemic hypotension: A risk factor for glaucomatous damage. Ophthalmologica 203:105-108, 1991.
2. Bechetoille, A., and Bresson-Dumont, H. Diurnal and nocturnal blood pressure drops in patients with local ischemic glaucoma. Graefe's Arch. Clin. Exp. Ophthalmol. 232:675-679, 1994.
3. Sergott, R.C., Aburn, N.S., Trible, J.R., et al. Color Doppler imaging: Methodology and preliminary results in glaucoma. Surv. Ophthalmol. 38(Suppl):S65-S71, 1994.
4. Rankin, S.J., Walman, B.E., Buckley, A.R., et al. Color Doppler imaging and spectral analysis of the optic nerve vasculature in glaucoma. Am. J. Ophthalmol. 119:685-693, 1995.
5. Guthoff, R.F., Berger, R.W., Winkler, P., et al. Doppler ultrasonography of the ophthalmic and central retinal vessels. Arch. Ophthalmol. 109:532-536, 1991.
6. Lieb, W.E., Cohen, S.M., Merton, D.A., et al. Color Doppler imaging of the eye and orbit: Technique and normal vascular anatomy. Arch. Ophthalmol. 109:527-531, 1991.
7. Butt, Z., Mckillop, G., O'Brian, C., et al. Measurement of ocular blood-flow velocity using color et al. Doppler imaging in low-tension glaucoma. Eye 9:29-33, 1995.
8. 2α with a hydroxyl or methoxy substitute provides biologically unique compounds. Br. J. Pharmacol. 130:1933-1943, 2000.
9. Brandt, J.D., VanDenburgh, A.M., Chen, K.K., et al. and the Bimatoprost Study Group. 1. Comparison of once- or twice-daily bimatoprost with twice-daily timolol in patients with elevated IOP: A 3-month clinical trial. Ophthalmology 108:1023-1030, 2001.
10. Cohen, J.S., Gross, R.L., Cheetham, J.K., et al. Two-year, double-masked comparison of bimatoprost with timolol in patients with glaucoma or ocular hypertension. Surv. Ophthaloml. 49(Suppl 1):S45-S52, 2004.
11. Planiol, T., Pourcelot, L., Pottier, J.-M., et al. Study of carotid circulation by means of ultrasonic methods and thermography [in French]. Rev. Neurol. (Paris) 126:127-141, 1972.
12. The Advanced Glaucoma Intervention Study Investigators. Advanced Glaucoma Intervention Study: 2. Visual field test scoring and reliability. Ophthalmology 101:1445-1455, 1994.
13. Hitchings, R.A., Wu, J., Poinoosawmy, D., et al. Surgery for normal tension glaucoma. Br. J. Ophthalmol. 79:402-406, 1995.
14. Collaborative Normal Tension Glaucoma Study Group. Comparison of glaucomatous progression between untreated patients with normal tension glaucoma and patients with therapeutically reduced intraocular pressure. Am. J. Ophthalmol. 126:487-497, 1998.
15. Membrey, W.L., Bunce, C., Poinnoosawmy, D.P., et al. Glaucoma surgery with or without adjunctive antiproliferatives in normal tension glaucoma: 2. Visual field progression. Br. J. Ophthalmol. 85:696-701, 2001.
16. Rulo, A.H., Greve, E.L., Geijssen, H.C., et al. Reduction of intraocular pressure with treatment of latanoprost once-daily in patients with normal-pressure glaucoma. Ophthalmology 103:1276-1282, 1996.
17. Liu, C.J., Ko, Y.C., Cheng, C.Y., et al. Changes in intraocular pressure and ocular perfusion pressure after latanoprost 0.005% or brimonidine tartrate 0.2% in normal tension glaucoma patients. Ophthalmology 109:2241-2247, 2002.
18. DuBinger, H., Cooke, D., Dirks, M., et al. Efficacy and safety of bimatoprost in patients with elevated intraocular pressure: A 30-day comparison with latanoprost. Surv. Ophthalmol. 45(Suppl 4):S353-S360, 2001.
19. Zeitz, O., Matthiessen, E.T., Reuss, J., et al. Effects of glaucoma drugs on ocular hemodynamics in normal tension glaucoma: A randomized trial comparing bimatoprostand latanoprost with dorzolamide. BMC Ophthalmol. 5:6, 2005.
20. Nouri-Mahdavi, K., Hoffman, D., Coleman, A.L., et al. Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study. Ophthalmology 111:1627-1635, 2004.
21. Sherwood, M., Brandt, J., and the Bimatoprsot Study Group 1 and 2. Six-month comparison of bimatoprost once- and twice-daily with timolol twice-daily in patients with elevated pressure. Surv. Ophthaloml. 45(Suppl 4):S361-S368, 2001.
22. Konstas, A.G., Katsimbris, J.M., Lallos, N., et al. Latanoprost 0.005% versus bimatoprost 0.03% in primary open-angle glaucoma. Ophthalmology 112:262-266, 2005.
23. Gherghel, D., Orgul, S., Gugleta, K., et al. Relationship between ocular perfusion pressure and retrobulbar blood flow in patients with glaucoma with progressive damage. Am. J. Ophthalmol. 130:597-605, 2000.
24. Fuchsjager-Mayrl, G., Wally, B., Georgopoulos, M., et al. Ocular blood flow and systemic blood pressure in patients with primary open-angle glaucoma and ocular hypertension. Invest. Ophthalmol. Vis. Sci. 45:834-839, 2004.
25. Emre, M., Orgül, S., Gugleta, K., et al. Ocular blood-flow alteration in glaucoma is related to systemic vascular dysregulation. Br. J. Ophthalmol. 88:662-666, 2004.
26. Graham, S.L., Drance, S.M., Wijsman, K., et al. Ambulatory blood-pressure monitoring in glaucoma: The nocturnal dip. Ophthalmology 102:61-69, 1995.
27. Riccadonna, M., Covi, G., Pancera, P., et al. Autonomic system activity and 24-h blood-pressure variations in subjects with normal- and high-tension glaucoma. J. Glaucoma 12:156-163, 2003.
28. Drance, S.M., Crichton, A., and Mills, R.P. Comparison of the effect of latanoprost 0.005% and timolol 0.5% on the calculated ocular perfusion pressure in patients with normal tension glaucoma. Am. J. Ophthalmol. 125:585-592, 1998.
29. Kaiser, H.J., Schotzau, A., and Flammer J. Blood-flow velocities in the extraocular vessels in normal volunteers. Am. J. Ophthalmol. 122:364-370, 1996.
30. 2α in human pial arteries. Acta. Physiol. Scand. 121:369-378, 1984.
31. 2α and latanoprost acid on isolated ocular blood vessels in vitro. J. Ocul. Pharmacol. Ther. 14:119-128, 1998.
32. Ishikawa, H., Yoshitomi, T., Mashimo, K., et al. Pharmacological effect of latanoprost, PG E2, and PGF2alpha on isolated rabbit ciliary artery. Graefe's Arch. Clin. Exp. Ophthalmol. 240:120-125, 2002.
33. Stjernschantz, J., Selén, G., Astin, M., et al. Effect of latanoprost on regional blood flow and capillary permeability in the monkey eye. Arch. Ophthalmol. 117:1363-1367, 1999.
34. Inan, U.U., Ermis, S.S., Orman, A., et al. The comparative cardiovascular, pulmonary, ocular blood flow, and ocular hypotensive effects of topical travoprost, bimatoprost, brimonidine, and betaxolol. J. Ocul. Pharmacol. Ther. 20:293-310, 2004.
35. Akarsu, C., Yilmaz, S., Taner, P., et al. Effect of bimatoprost on ocular circulation in patients with open-angle glaucoma or ocular hypertension. Graefe's Arch. Clin. Exp. Ophthalmol. 242:814-818, 2004.
36. Harris, A., Joos, K.M., and Kay, M.D. Acute IOP elevation with scleral suction: Effects on retrobulbar hemodynamics. Br. J. Ophthalmol. 80:1-5, 1996.
37. Joos, K.M., Kay, M.D., and Pillunat, L.E. The effect of acute intraocular pressure changes on short posterior ciliary artery hemodynamics. Br. J. Ophthalmol. 83:33-38, 1999.